Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9828

Toxic equivalency factor evaluation (TCDD): Target Organs and Levels of Evidence for TR-521

Toxicology and Carcinogenesis Studies of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (CASRN 1746-01-6) in Female Harlan Sprague-Dawley Rats (Gavage Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
TEF evaluation (TCDD)
1746-01-6		02/17/2004Gavage
FEMALE RATS ONLY: TCDD -- 0, 3, 10, 22, 46, OR 100 NG/KG; 100/DOSE		Battelle Columbus Laboratory

Levels of Evidence

Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 0/53 0/54 0/53 0/53 1/53 13/53 2/50 OR CHOLANGIOCARCINOMA 0/53 0/54 0/53 1/53 4/53 25/53 2/50
  • Lung: CYSTIC KERATINIZING EPITHELIOMA 0/53 0/54 0/53 0/52 0/53 9/52 0/50
  • Oral Cavity: GINGIVAL SQAMOUS CELL CARCINOMA (ORAL MUCOSA) 1/53 2/54 1/53 0/53 4/53 10/53 5/50
  • Uterus/Cervix: SQUAMOUS CELL CARCINOMA 0/53 0/54 0/53 0/53 5/53 0/53 2/50
May Have Been Related
  • Pancreas Acinar Cell: ADENOMA OR CARCINOMA 0/51 0/54 0/52 0/53 0/52 3/51 1/49
  • Liver: HEPATOCHOLANGIOMA 0/53 0/54 0/53 0/53 0/53 2/53 0/50 OR CHOLANGIOMA 0/53 0/54 0/53 0/53 0/53 0/53 1/50
Non-Neoplastic Lesions
  • LIVER: HEPATOCYTE HYPERTROPHY; MULTINUCLEATED HEPATOCYTE; EOSINOPHILIC FOCUS; INFLAMMATION; PIGMENTATION; DIFFUSE FATTY CHANGE; NECROSIS; OVAL CELL HYPERPLASIA; BILE DUCT HYPERPLASIA; BILE DUCT CYST; NODULAR HYPERPLASIA; PORTAL FIBROSIS; TOXIC HEPATOPATHY; CHOLANGIOFIBROSIS
  • LUNG: ALVEOLAR EPITHELIUM, METAPLASIA, BRONCHIOLAR
  • ORAL MUCOSA: GINGIVAL SQUAMOUS HYPERPLASIA
  • PANCREAS: ACINAR CYTOPLASMIC VACUOLIZATION; CHRONIC ACTIVE INFLAMMATION; ACINAR ATROPHY; ARTERIAL CHRONIC ACTIVE INFLAMMATION
  • THYMUS: ATROPHY; SEVERITY OF ATROPHY
  • ADRENAL CORTEX: ATROPHY; HYPERPLASIA
  • HEART: CARDIOMYOPATHY
  • CLITORAL GLAND: CYSTIC DUCT
  • KIDNEY: NEPHROPATHY; SEVERITY OF NEPHROPATHY
  • FORESTOMACH: SQUAMOUS HYPERPLASIA
  • MESENTERY: CHRONIC ACTIVE ARTERY INFLAMMATION
  • THYROID GLAND: FOLLICULAR CELL HYPERTROPHY